Pharmacogenetics

Pharmacogenetics

Pharmacogenetics is the study of the effects of individual genetics on drug responses. This book provides an overview of the current state of the pharmacological genetic aspects of these treatments. It discusses drugs with genetic information to support product labeling, clinical guidelines, or sign...

Full description

Bibliographic Details
Format:	eBook
Language:	English
Published:	IntechOpen 2021
Subjects:	Pharmacology biomarkers, alzheimer's disease, immunotherapy, neurodegeneration, hypoxia, lung cancer
Online Access:	Open Access: DOAB: description of the publication Open Access: DOAB, download the publication

Similar Items

Perspective of SGLT2 Inhibition in Treatment of Conditions Connected to Neuronal Loss: Focus on Alzheimer’s Disease and Ischemia-Related Brain Injury
by: Michał Wiciński, et al.
Published: (2020-11-01)

Clinical Applications of Pharmacogenetics
Published: (2012)

New Features about Tau Function and Dysfunction
by: Miguel Medina, et al.
Published: (2016-04-01)

Use of ocular biomarkers as a potential tool for early diagnosis of Alzheimer's disease
by: Ajay K Singh, et al.
Published: (2020-01-01)

Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery
by: Francesca Romana Buccellato, et al.
Published: (2021-08-01)

Alteration of Iron Concentration in Alzheimer’s Disease as a Possible Diagnostic Biomarker Unveiling Ferroptosis
by: Eleonora Ficiarà, et al.
Published: (2021-04-01)

Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer’s disease
by: Malcolm Roberts, et al.
Published: (2020-02-01)

Editorial: Risk Factors and Outcome Predicating Biomarker of Neurodegenerative Diseases
by: Chaur-Jong Hu, et al.
Published: (2019-02-01)

Pharmacological Modulators of Small GTPases of Rho Family in Neurodegenerative Diseases
by: William Guiler, et al.
Published: (2021-05-01)

Early Events in Diabetic Retinopathy and Intervention Strategies
Published: (2018)

The Role of Molecular Profiling to Predict the Response to Immune Checkpoint Inhibitors in Lung Cancer
by: Courèche Kaderbhaï, et al.
Published: (2019-02-01)

Longitudinal trajectories of Alzheimer’s ATN biomarkers in elderly persons without dementia
by: Meng-Shan Tan, et al.
Published: (2020-05-01)

Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology
by: Marc Suárez-Calvet, et al.
Published: (2019-01-01)

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer’s disease
by: Kalicharan Patra, et al.
Published: (2018-01-01)

The Eye as a Biomarker for Alzheimer’s Disease
by: Jeremiah Kah Heng Lim, et al.
Published: (2016-11-01)

Prognostic value of ATN Alzheimer biomarkers: 60‐month follow‐up results from the Argentine Alzheimer's Disease Neuroimaging Initiative
by: Ricardo F. Allegri, et al.
Published: (2020-01-01)

A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis
by: Tim West, et al.
Published: (2021-05-01)

Cerebrospinal fluid ferritin levels predict brain hypometabolism in people with underlying β-amyloid pathology
by: Ibrahima Diouf, et al.
Published: (2019-04-01)

Brain SPECT as a Biomarker of Neurodegeneration in Dementia in the Era of Molecular Imaging: Still a Valid Option?
by: Rodolfo Ferrando, et al.
Published: (2021-05-01)

TREML2 Mutation Mediate Alzheimer’s Disease Risk by Altering Neuronal Degeneration
by: Ya-Nan Song, et al.
Published: (2019-05-01)

Preclinical and clinical issues in Alzheimer's disease drug research and development
Published: (2015)

Sleep–Wake Cycle and EEG-Based Biomarkers during Neonate to Adult Transition in C57BL/6 Mice
by: Miguel A. Herrero, et al.
Published: (2021-02-01)

Body Fluid Biomarkers for Alzheimer’s Disease—An Up-To-Date Overview
by: Adrian Florian Bălașa, et al.
Published: (2020-10-01)

Retinal thickness as a potential biomarker in patients with amyloid‐proven early‐ and late‐onset Alzheimer's disease
by: Jurre denHaan, et al.
Published: (2019-12-01)

Dynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study
by: Ling-Zhi Ma, et al.
Published: (2020-04-01)

Relationship between frailty and Alzheimer's disease biomarkers: A scoping review
by: Lindsay Wallace, et al.
Published: (2018-01-01)

A Note on Changing Approach to Diagnosis of Alzheimer’s Disease
by: Antonio Tartaglione, et al.
Published: (2013-07-01)

Overestimating the effects of healthy aging
by: Vanja eKljajevic
Published: (2015-08-01)

Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies
by: Kira S Sheinerman, et al.
Published: (2013-09-01)

Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP)
by: Andrea Sturchio, et al.
Published: (2020-10-01)

Nanoliposomes as a Therapeutic Tool for Alzheimer’s Disease
by: Lara Ordóñez-Gutiérrez, et al.
Published: (2020-05-01)

Amyloid Precursor Protein-Dependent and -Independent Mechanisms in Hypoxia-Induced Axonopathy
by: Christianson, Melissa Gottron
Published: (2012)

Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer
by: Loïck Galland, et al.
Published: (2021-06-01)

Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine Approach
by: Eleonora Del Prete, et al.
Published: (2020-11-01)

Immunotherapy Advances in Small Cell Lung Cancer
by: Yangyang XU, et al.
Published: (2020-11-01)

Alzheimer's Disease: Original Mechanisms and Translational Impact
Published: (2020)

Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases
by: Dorit Trudler, et al.
Published: (2021-07-01)

Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia
by: Franc Llorens, et al.
Published: (2017-09-01)

Molecular diagnostics of neurodegenerative disorders
by: Megha eAgrawal, et al.
Published: (2015-09-01)

Chromosomal Abnormalities A Hallmark Manifestation of Genomic Instability
Published: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9pq6lmr26en68v1aa82mlie5nd